Table 1 Total number (N) of patients and median FBA concentrations with IQR in each patient cohort based on their SeHCAT result. BAD idiopathic BAD, PC post-cholecystectomy, CD post-operative Crohn’s disease patients, CG SeHCAT negative control group.

From: A single faecal bile acid stool test demonstrates potential efficacy in replacing SeHCAT testing for bile acid diarrhoea in selected patients

SeHCAT result

BAD

PC

CD

CG

N

FBA

N

FBA

N

FBA

N

FBA

< 5%

7

8.2 (4.2–16.9)

8

5.6 (4.0–8.1)

16

11.8 (10.1–16.2)

 

5–10%

12

2.1 (1.4–5.0)

9

3.2 (2.0–6.2)

 

10–15%

14

3.2 (2.5–4.8)

3

2.8 (1.3–4.3)

> 15%

 

7

2.5 (1.1–4.0)

1

12.5

36

2.8 (1.6–4.2)

Back to article page